Latest News

GeoVax Provides Update on its Zika Vaccine Development
Presentation Made During 11th Vaccine Congress in San Diego GeoVax Labs, Inc. (OTCQB: GOVX), a biot...
Continue Reading...
GeoVax Presents Zika Vaccine Data at Scientific Conference
Vaccine Based on Zika NS1 Protein Achieved 100% Protection in Lethal Challenge Model with a Single I...
Continue Reading...
GeoVax Presents Preliminary Data for Cancer Vaccine
Data Presented at Immuno-Oncology Summit GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company d...
Continue Reading...